美國居民不適用 XM 服務。

BlackRock adds concentrated equity, high-yield ETFs to its roster



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>CORRECTED-BlackRock adds concentrated equity, high-yield ETFs to its roster</title></head><body>

Corrects size of portfolio to 20 to 25 stocks, not 20 to 24 stocks in third paragraph, adds "large cap" to paragraph 4

By Suzanne McGee

June 18 (Reuters) -BlackRock Inc BLK.N, the world's largest asset manager with $2.8 trillion in 400-plus exchange-traded funds, has added two more products to its roster of actively managed ETFs, it said on Tuesday.

The new funds are managed by teams overseeing similar or nearly identical strategies as mutual funds.

The BlackRock Long-Term U.S. Equity ETF BELT.O offers access to a concentrated portfolio of 20 to 25 stocks ranging from Intuitive Surgical ISRG.O and Intuit INTU.O to Chipotle Mexican Grill CMG.N.

The fund invests in competitive large-cap companies that can consistently boost cash flow, regardless of sector, said Jay Jacobs, head of thematic and active ETFs.

The BlackRock High Yield ETF BRHY.O will hold 80% to 100% of its assets in high yield bonds rated BB to CCC, but can also invest in other securities, such as bank loans, investment-grade bonds and convertible securities, he added.

BlackRock has 40 active ETFs, nearly double the number two years ago. About $25 billion of its total $2.8 trillion ETF assets are in actively managed products.

So far this year, active ETFs have accounted for about 85% of all new ETF launches, 44% of total ETF listings and about a third of all inflows in the United States, according to Goldman Sachs Asset Management.




Reporting by Suzanne McGee; Editing by Richard Chang

</body></html>

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明